Andrea Ellis serves as Executive at BridgeBio Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Andrea Ellis has executed 3 insider transactions totaling $941.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 5, 2025 involved selling 17,167 shares valued at $841.2K.
Andrea Ellis currently holds 18,589 shares of BridgeBio Pharma, Inc. (BBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrea Ellis has been a net seller of BBIO stock. They have purchased $100.7K and sold $841.2K worth of shares.
Andrea Ellis's most recent insider trade was on Aug 5, 2025, when they sold 17,167 shares at $49.00 per share.
Get notified when new Form 4 filings are submitted
| $16.75 |
| Discretionary |
| Mar 15, 2022 | BBIO | $100.7K | Purchase | 12,000 | $8.39 | Discretionary |